I agree with everything you stated. Even if, Abbott was unsuccessful in incorporating the Recaf into their Architect system, I'm confident that Recaf would hit the market as a stand alone blood serum test. The technology holds too much promise to just be ignored. It's just a matter of time, and at 39 I have plenty of it, at least I hope so!